Download video

Dr. Sanjay Popat, Where the Dust Has Settled with Adjuvant Osimertinib After ADAURA Trial | BTJ-003

215 views

BeaconMedIC

4 years ago

Dr. Sanjay Popat, Where the Dust Has Settled with Adjuvant Osimertinib After ADAURA Trial | BTJ-003

Dr. Sanjay Popat, Where the Dust Has Settled with Adjuvant Osimertinib After ADAURA Trial | BTJ-003

Dr. Sanjay Popat, Where the Dust Has Settled with Adjuvant Osimertinib After ADAURA Trial | BTJ-003
48:31
Dr. Sanjay Popat, Where the Dust Has Settled with Adjuvant Osimertinib After ADAURA Trial | BTJ-003
by BeaconMedIC
Dr. Sanjay Popat (Pt 2): Precision Medicine and Therapy in a Nationalized, Regulated System
26:07
Dr. Sanjay Popat (Pt 2): Precision Medicine and Therapy in a Nationalized, Regulated System
by BeaconMedIC
Updates from ADAURA: continued DFS benefit with osimertinib vs. placebo
3:13
Updates from ADAURA: continued DFS benefit with osimertinib vs. placebo
by VJOncology
ADAURA: the benefit of adjuvant osimertinib
1:42
ADAURA: the benefit of adjuvant osimertinib
by VJOncology
Dr. Levy on the DFS Benefit Achieved With Adjuvant Osimertinib in EGFR+ NSCLC
1:37
Dr. Levy on the DFS Benefit Achieved With Adjuvant Osimertinib in EGFR+ NSCLC
by OncLive
In conversation with...Professor Sanjay Popat
21:17
In conversation with...Professor Sanjay Popat
by Mesothelioma UK
Horizon scanning in lung cancer
1:42
Horizon scanning in lung cancer
by VJOncology
Adayulogues with Dr. Samir Parikh | Ep. 16 | ऑटिज्म स्पेक्ट्रम | एस्पर्जर सिन्ड्रोम | Part 2
15:43
Adayulogues with Dr. Samir Parikh | Ep. 16 | ऑटिज्म स्पेक्ट्रम | एस्पर्जर सिन्ड्रोम | Part 2
by Fortis Mental Health and Behavioural Sciences
What is Central Serous Retinopathy ? || Symptoms, Diagnosis \& Treatment
8:56
What is Central Serous Retinopathy ? || Symptoms, Diagnosis \& Treatment
by Friendly Doctor
Postcath Conference 17 April
1:29:00
Postcath Conference 17 April
by Cardiology Department Ain Shams
BTOG 2020: what to expect
1:21
BTOG 2020: what to expect
by VJOncology
Reflections on the ADAURA study
4:24
Reflections on the ADAURA study
by VJOncology
Role of Adjuvant Osimertinib in Early Stage NSCLC
10:20
Role of Adjuvant Osimertinib in Early Stage NSCLC
by OncLive
Prof. Popat: BTOG 2020 hot topics
2:59
Prof. Popat: BTOG 2020 hot topics
by VJOncology
Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way
59:19
Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way
by PeerView Oncology
Defining Cure in Cancer: Dr. Jonathan Spicer and Dr. Sanjay Popat
13:07
Defining Cure in Cancer: Dr. Jonathan Spicer and Dr. Sanjay Popat
by astrazeneca
Checkmate 227: Final analysis for the non small cell lung cancer trial
3:04
Checkmate 227: Final analysis for the non small cell lung cancer trial
by ecancer
ALTA-1L: Brigatinib vs crizotinib for ALK+ advanced non small cell lung cancer patients
5:51
ALTA-1L: Brigatinib vs crizotinib for ALK+ advanced non small cell lung cancer patients
by ecancer
Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC
3:19
Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC
by PracticeUpdate
Dr. Sanjay Popat (Pt 1): The Path to Leadership in Thoracic Oncology in the UK
27:05
Dr. Sanjay Popat (Pt 1): The Path to Leadership in Thoracic Oncology in the UK
by BeaconMedIC
ASCO Lung Cancer Roundtable - Trial Updates in NSCLC - ADAURA Trial and Post Surgery EGFR Mutation
16:41
ASCO Lung Cancer Roundtable - Trial Updates in NSCLC - ADAURA Trial and Post Surgery EGFR Mutation
by GRACE - Global Resource for Advancing Cancer Education